首页 | 本学科首页   官方微博 | 高级检索  
     


Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents
Authors:Amit Bahl  Susan Masson  Alison Birtle  Simon Chowdhury  Johann de Bono
Affiliation:1. Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation,UK;2. Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK;3. Guy''s and St Thomas'' NHS Foundation Trust, London, UK;4. The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK
Abstract:
Keywords:Prostate cancer   Metastatic   Castration-resistant   Cabazitaxel   Abiraterone   Enzalutamide
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号